Wells Fargo Upgrades Infinity Pharmaceutical (INFI) to Overweight, Sees Upside to $30
Tweet Send to a Friend
(Updated - July 28, 2021 9:28 AM EDT)Wells Fargo analyst Nick Abbott upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Equal Weight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE